The following is an FDA safety communication regarding updated warnings for RSV vaccines Abrysvo and Arexvy. FDA Safety Communication Purpose: To inform the public and healthcare providers that FDA has required and approved safety labeling changes to the Prescribing Information for […]
FDA alert: Warning added to RSV vaccines for Guillain-Barré risk Read More »
The following information is from Children’s Health Defense. Advisers to the FDA recently met to discuss the future of respiratory syncytial virus (RSV) vaccines for children. This followed Moderna’s forced halt of its mRNA RSV vaccine trials after alarming data showed
FDA pushes RSV vaccines for kids despite halted Moderna trials Read More »
The following is from Becker’s Hospital Review. More than 25 infants under 8 months old and 128 pregnant women received the incorrect respiratory syncytial virus vaccines, the CDC warned clinicians via email Jan. 22. The 128 pregnant women received Arexvy,
(CDC) 150+ babies, pregnant women given wrong RSV vaccine Read More »
